Glaxosmithkline Share News (GSK)

Haleon Q1 profit misses analyst expectations

LONDON, May 3 (Reuters) - Haleon, the world's biggest standalone consumer health business, on Wednesday reported first-quarter profit below analyst expectations.

US FDA panel backs restricted use of AstraZeneca's prostate cancer drug

April 28 (Reuters) - A panel of U.S. Food and Drug Administration advisers on Friday voted for the restricted use of British drugmaker AztraZeneca Plc's experimental treatment, jointly developed with Merck & Co, for a type of prostate cancer.

GSK gets positive EU opinion for respiratory syncytial virus vaccine

(Alliance News) - GSK PLC on Thursday said its respiratory syncytial virus vaccine candidate has gained positive opinion from the European Medicines Agency body.

IN BRIEF: Schroders taps PwC exec as CFO, GSK CFO as non-exec director

Schroders PLC - London-based investment manager - Hires Richard Oldfield to succeed Richard Keers as chief financial officer and an executive director. Oldfield currently is vice chair & global markets leader at accountants PricewaterhouseCoopers. Oldfield will join Schroders on October 2, and Keers will depart on December 31 after 10 years with the company. At Schroders, Oldfield will be responsible for "firm-wide operations" and for "financial management, risk management, technology, capital and treasury".

EMA adopts 'positive opinion' of GSK's RSV vaccine candidate

(Sharecast News) - GSK updated the market on its respiratory syncytial virus (RSV) vaccine candidate for older adults on Thursday, reporting that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) had adopted a positive opinion by consensus.

GSK's RSV vaccine first to get EU regulator's nod

EMA recommends authorization of first RSV vaccine

*

European shares fall as healthcare stocks hit by drug reforms

Healthcare index marks biggest decline in 15 months

*

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight.

UK shareholder meetings calendar - next 7 days

EU publishes proposed drug laws overhaul, seting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its vaccines as well as HIV and respiratory medicines.

EU publishes proposed drug laws overhaul, setting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines.

TOP NEWS: GSK quarterly sales and profit slips; confirms outlook

(Alliance News) - Brentford, London-based GSK PLC on Wednesday reported a slip in quarterly sales, but confirmed its 2023 guidance.

LONDON BRIEFING: GSK quarterly sales slip but confirms 2023 guidance

(Alliance News) - Stocks in London were set to open lower on Wednesday as worries about the US banking sector returned.